Gut microbiota-derived propionate mediate... - Cure Parkinson's

Cure Parkinson's

25,550 members26,870 posts

Gut microbiota-derived propionate mediates the neuroprotective effect of osteocalcin in a mouse model of Parkinson’s disease 2021

Bolt_Upright profile image
0 Replies

Interesting stuff. That osteocalcin (OCN) looks useful, but so does proprionate.

Here is the full study:

microbiomejournal.biomedcen...

The finding in our study demonstrated that OCN increased the microbial propionate production, which might activate FFAR3 in enteric neurons, to exert its protective effect on PD. Using a mouse model of 6-OHDA-induced PD, the current study demonstrated that OCN can prevent motor impairments and dopaminergic neuronal loss in PD mice. Our data further suggested that OCN can exert protective effect via regulating microbial metabolism of SCFAs and increasing gut microbiota-derived propionate levels in PD mice. Furthermore, the oral administration of propionate showed protective effect against PD, suggested that microbial propionate production was a potential target for PD intervention. And our data suggested that propionate mainly acted on FFAR3 in enteric neurons to exert its neuroprotective effects on PD.

Written by
Bolt_Upright profile image
Bolt_Upright
To view profiles and participate in discussions please or .
Read more about...

You may also like...

Parkinson’s Disease: Can Targeting Inflammation Be an Effective Neuroprotective Strategy? 2021

Disease: Can Targeting Inflammation Be an Effective Neuroprotective Strategy?...

Must Read: Gut Microbiota: A Novel Therapeutic Target for Parkinson’s Disease 24 June 2022

937555/full \\"Although the cause-effect links between gut microbiota and PD remain unclear,...

Effects of concomitant use of hydrogen water and photobiomodulation on Parkinson disease 2021

Conclusion: This novel, proof-of-concept study demonstrated that PBM+H2 therapy is safe and reduces...

dietary propionate can alleviate Parkinson’s disease symptoms

The mechanistic role of thymoquinone in Parkinson's disease: focus on neuroprotection in pre-clinical studies 2021

Parkinson's disease: focus on neuroprotection in pre-clinical studies...